Blood Bags Market

By Product Type;

Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag, and Penta Blood Bag

By Type;

Collection Bag and Transfer Bag

By Volume;

100Ml, 150Ml, 250Ml, 300Ml, 350Ml, 400Ml, 450Ml, and 500Ml

By Material;

PVC, PET, and Others

By End-User;

Hospitals, Clinics, Ambulatory Surgical Center, Blood Banks, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn255199005 Published Date: September, 2025 Updated Date: October, 2025

Blood Bags Market Overview

Blood Bags Market (USD Million)

Blood Bags Market was valued at USD 296.70 million in the year 2024. The size of this market is expected to increase to USD 556.46 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.4%.


Blood Bags Market

*Market size in USD million

CAGR 9.4 %


Study Period2025 - 2031
Base Year2024
CAGR (%)9.4 %
Market Size (2024)USD 296.70 Million
Market Size (2031)USD 556.46 Million
Market ConcentrationMedium
Report Pages366
296.70
2024
556.46
2031

Major Players

  • Terumo Corporation
  • Fresenius SE & Co. KGaA
  • Grifols S.A
  • Macopharma
  • Haemonetics Corporation
  • Kawasumi Laboratories, Inc
  • Advacare Pharma
  • Neomedic Limited
  • Innvol Medical India Limited
  • SURU International Pvt Ltd

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Blood Bags Market

Fragmented - Highly competitive market without dominant players


The Blood Bags Market is expanding as healthcare facilities prioritize safe and sterile blood storage solutions. Around 40% of institutions are adopting disposable bags to enhance transfusion practices and improve overall patient care. This steady adoption reflects the growing need for advanced storage technologies that ensure safety, reliability, and efficiency in medical applications.

Adoption in Healthcare Infrastructure
Hospitals and clinics are increasingly transitioning to single-use blood collection systems, with over 45% of facilities integrating them into their infrastructure. This move not only minimizes contamination risks but also supports the rising demand from trauma centers and surgical departments. Their importance in routine healthcare and critical care highlights their essential role in medical ecosystems.

Technological Improvements Enhancing Efficiency
Technological advancements are reshaping the market with multi-bag systems and improved anticoagulant integration. Nearly 50% of the new installations now incorporate these designs to reduce wastage and preserve quality. Such innovations are helping providers meet higher donation volumes while ensuring strict compliance with safety protocols.

Sustainability and Quality Focus
Manufacturers are also focusing on sustainable and high-quality materials, with close to 30% of producers investing in eco-friendly alternatives. Emphasis on infection control, durability, and regulatory alignment ensures that blood bags continue to meet evolving healthcare demands while supporting environmental initiatives.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Type
    3. Market Snapshot, By Volume
    4. Market Snapshot, By Material
    5. Market Snapshot, By End-User
    6. Market Snapshot, By Region
  4. Blood Bags Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing blood transfusion procedures worldwide
        2. Growing demand for safe blood storage
        3. Rising prevalence of chronic diseases
        4. Technological advancements in blood bags
      2. Restraints
        1. Stringent regulations and standards
        2. Concerns regarding blood safety
        3. Limited availability of skilled professionals
        4. High cost of blood bag systems
      3. Opportunities
        1. Emerging markets in developing countries
        2. Innovations in blood bag materials
        3. Expansion of blood donation programs
        4. Rising healthcare expenditure globally
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Blood Bags Market, By Product Type, 2021 - 2031 (USD Million)
      1. Single Blood Bag
      2. Double Blood Bag
      3. Triple Blood Bag
      4. Quadruple Blood Bag
      5. Penta Blood Bag
    2. Blood Bags Market, By Type, 2021 - 2031 (USD Million)
      1. Collection Bag
      2. Transfer Bag
    3. Blood Bags Market, By Volume, 2021 - 2031 (USD Million)
      1. 100Ml
      2. 150Ml
      3. 250Ml
      4. 300Ml
      5. 350Ml
      6. 400Ml
      7. 450Ml
      8. 500Ml
    4. Blood Bags Market, By Material, 2021 - 2031 (USD Million)
      1. PVC
      2. PET
      3. Others
    5. Blood Bags Market, By End-User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinics
      3. Ambulatory Surgical Center
      4. Blood Banks
      5. Others
    6. Blood Bags Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Terumo Corporation
      2. MacoPharma
      3. Fresenius SE & Co. KGaA
      4. Haemonetics Corporation
      5. Grifols SA
      6. Kawasumi Laboratories
      7. JMS Co. Ltd.
      8. Poly Medicure Limited
      9. HLL Lifecare
      10. Neomedic International
      11. AdvaCare Pharma
      12. Suru International
      13. GVS S.p.A.
      14. Qingdao Sinoland International Trade
      15. B. Braun
    2. Analyst Views
    3. Future Outlook of the Market